Walleye Capital
ALXO icon

Walleye Capital’s ALX Oncology ALXO Stock Holding History

Walleye Capital’s Portfolio ALXO Stock Details ALXO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$1.01M Buy
+729,675
New +$1.41M ﹤0.01% 3474
2024
Q4 		– Sell
-230,875
Closed -$420K – 4788
2024
Q3 		$420K Buy
230,875
+121,113
+110% +$450K ﹤0.01% 3460
2024
Q2 		$662K Buy
109,762
+71,521
+187% +$879K ﹤0.01% 3252
2024
Q1 		$426K Sell
38,241
-39,589
-51% -$556K ﹤0.01% 3337
2023
Q4 		$1.16M Buy
+77,830
New +$738K ﹤0.01% 2226
2022
Q1 		– Sell
-58,744
Closed -$1.26M – 2263
2021
Q4 		$1.26M Buy
+58,744
New +$2.53M 0.04% 472

Other funds holding ALXO

BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Silverarc Capital Management
Silverarc Capital Management Boston, Massachusetts $854M AUM 179.73% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
Marshall Wace
Marshall Wace London, United Kingdom $114B AUM 35.47% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $85.7B AUM 51.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.84T AUM 33.86% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM

Walleye Capital's ALXO Position: Q3 2026 in Review

Walleye Capital opened a new position in ALX Oncology (ALXO) in Q3 2026: 729,675 shares worth $1.01M. The stake represents ﹤0.01% of the portfolio and ranks #3474 among its holdings. This is a return to the name: Walleye Capital previously reported a position in ALXO as recently as Q3 2024.

Walleye Capital first reported a position in ALXO in Q4 2021 and has held it in 6 quarters since. The position peaked at $1.26M in Q4 2021. 65 funds tracked by Wall St. Rank hold ALXO as of Q3 2026.

  • Walleye Capital held 729,675 shares of ALX Oncology worth $1.01M as of Q3 2026.
  • ALX Oncology was a new Walleye Capital position in Q3 2026.
  • ALX Oncology made up ﹤0.01% of Walleye Capital's portfolio in Q3 2026, its #3474 holding.
  • Walleye Capital first reported a position in ALX Oncology in Q4 2021 and has held it in 6 quarters since.
  • Walleye Capital's ALX Oncology position peaked at $1.26M in Q4 2021.
  • 65 funds tracked by Wall St. Rank held ALX Oncology as of Q3 2026.

Based on Walleye Capital's 13F filing for Q3 2026, filed 13 Nov 2026.